Klaus Charissé
Klaus Charissé publishes mostly in Molecular Biology, Cancer Research and Neurology, on topics such as RNA Interference and Gene Delivery, Advanced biosensing and bioanalysis techniques and DNA and Nucleic Acid Chemistry.
- World rank
- #175,411 of 7,710,434 ranked researchers
- Rank in United States
- #65,570 of 1,627,098
- Works
- 105
- Citations
- 12k
- Citations per work
- 109.6
What does Klaus Charissé research?
Klaus Charissé's work is mostly in Biochemistry, Genetics and Molecular Biology (84%), Medicine (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences8883.6%
- Everything else1211.2%
- Health Sciences55.2%
- Medicine55.2%
- 1Molecular Biology74% of their works
- 2Cancer Research8% of their works
- 3Neurology2% of their works
- 4Biotechnology2% of their works
- 5Surgery2% of their works
- 6Hematology2% of their works
Research topics
Which keywords describe Klaus Charissé's research?
The keywords of their largest research topics: Gene Therapy, RNA Interference, siRNA Delivery, DNA nanotechnology, Self-Assembly, DNA Structure, G-Quadruplexes and Gene Expression.
- Bacterial Therapy
- Alternative Splicing
- Ribosome
- RNA methylation
- Gene Expression
- DNA Structure
- DNA nanotechnology
- RNA Interference
- Gene Therapy
- siRNA Delivery
- Self-Assembly
- G-Quadruplexes
- MicroRNA
- m6A-seq
- Translation
- RNA-Binding Proteins
- Tumor Targeting
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Gene Therapy662 topics
- RNA Interference621 topic
- siRNA Delivery621 topic
- DNA nanotechnology421 topic
- Self-Assembly421 topic
- DNA Structure211 topic
- G-Quadruplexes211 topic
- Gene Expression151 topic
- MicroRNA151 topic
- RNA methylation151 topic
- m6A-seq151 topic
- Ribosome121 topic
- Translation121 topic
- Alternative Splicing61 topic
- RNA-Binding Proteins61 topic
- Bacterial Therapy41 topic
- Tumor Targeting41 topic
Where does Klaus Charissé work?
Klaus Charissé's main affiliation in the publication record is Alnylam Pharmaceuticals (United States), United States.
How many publications and citations does Klaus Charissé have?
OpenAlex counts 105 works and 11,504 citations for Klaus Charissé, an h-index of 41, ranking #175,411 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Klaus Charissé. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.